Novocure (NVCR) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Join SI Premium – FREE
Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.28), $0.05 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $155.1 million versus the consensus estimate of $143.84 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crude Inventory Fell 1.7 Million Barrels Last Week - EIA
- Stifel: 'We are incrementally more constructive on TXN'
- Morgan Stanley shares gain as equities trading, dealmaking fuel Q2 earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
